Literature DB >> 8288424

Social evaluation of health care versus personal evaluation of health states. Evidence on the validity of four health-state scaling instruments using Norwegian and Australian surveys.

E Nord1, J Richardson, K Macarounas-Kirchmann.   

Abstract

In most of the cost-utility literature, quality-adjusted life-year (QALY) gains are interpreted as a measure of social value. Given this interpretation, the validity of different multi-attribute health-state scaling instruments may be tested by comparing the values they provide on the 0-1 QALY scale with directly elicited preferences for person trade-offs between different treatments (equivalence of numbers of different patients treated). Norwegian and Australian public preferences as measured by the person trade-off suggest that the EuroQol Instrument assigns excessively low values to health states. This seems to be even more true of the McMaster Health Classification System. The Quality of Well-being Scale appears to compress states toward the middle of the 0-1 scale. By contrast, the Rosser/Kind index fits reasonably well with directly measured person trade-off data.

Entities:  

Mesh:

Year:  1993        PMID: 8288424     DOI: 10.1017/s0266462300005390

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  17 in total

1.  The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life.

Authors:  G Hawthorne; J Richardson; R Osborne
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

2.  From selfish individualism to citizenship: avoiding health economics' reputed 'dead end'.

Authors:  V Wiseman
Journal:  Health Care Anal       Date:  1998-06

3.  Valuation of EuroQOL (EQ-5D) health states in an adult US sample.

Authors:  J A Johnson; S J Coons; A Ergo; G Szava-Kovats
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

4.  Severity as an independent determinant of the social value of a health service.

Authors:  Jeff R J Richardson; John McKie; Stuart J Peacock; Angelo Iezzi
Journal:  Eur J Health Econ       Date:  2010-05-09

Review 5.  Resource allocation, social values and the QALY: a review of the debate and empirical evidence.

Authors:  David L B Schwappach
Journal:  Health Expect       Date:  2002-09       Impact factor: 3.377

Review 6.  Willingness to pay for a QALY: theoretical and methodological issues.

Authors:  Dorte Gyrd-Hansen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

7.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.

Authors:  Knut Stavem; Stig S Frøland; Kjell B Hellum
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

8.  Cost-value analysis of health interventions: introduction and update on methods and preference data.

Authors:  Erik Nord
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

9.  Theory of constraints for publicly funded health systems.

Authors:  Somayeh Sadat; Michael W Carter; Brian Golden
Journal:  Health Care Manag Sci       Date:  2012-08-21

10.  Transforming EQ-5D utilities for use in cost–value analysis of health programs.

Authors:  Erik Nord; Rune Johansen
Journal:  Eur J Health Econ       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.